[DOI] [PMC free article] [PubMed] [Google Scholar] 138.RCP Royal College of Psychiatrists
Does allulose affect hunger hormones
The highly conserved mechanistic target of rapamycin (mTOR) regulates protein synthesis, metabolism and growth
Licensing (Marketing Authorisation): The MHRA has approved: Semaglutide (Wegovy) for adults with BMI 30 kg/m or BMI 27 kg/m with at least one weight-related comorbidity Liraglutide (Saxenda) with similar BMI criteria NHS Access (NICE Guidance): According to NICE guidance (TA664 for semaglutide), NHS-funded treatment is more restricted and typically available for adults with: BMI 35 kg/m with at least one weight-related comorbidity (such as hypertension, type 2 diabetes, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease) For individuals from Black, Asian, and minority ethnic backgrounds, lower BMI thresholds may apply, recognising that these populations face increased metabolic risk at lower BMI levels
Dace Trence, MD, a professor emeritus of medicine at the University of Washington and the president of the American Association of Clinical Endocrinology, concurs that a chief benefit of generic GLP-1 medications is their cost-effectiveness
Zhang C
